APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advance Directives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Advance Directives Market Outlook and Growth Opportunities 2026

5 March 2026208 pages

Choose your research edition.

Industry ResearchAdvance Directives Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Advance Directives Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Advance Directives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advance Directives Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Advance Directives Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Advance Directives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Advance Directives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Advance Directives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Advance Directives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Advance Directives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Advance Directives market include ADvault, VyncaCare, WiserCareInc, Sharp HealthCare, ACP Decisions, lris, Healthcare, Bronson Health Care Group and Koda Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Advance Directives market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Advance Directives and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Advance Directives revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Advance Directives market.

Advance Directives Segment by Company

ADvault

VyncaCare

WiserCareInc

Sharp HealthCare

ACP Decisions

lris

Healthcare

Bronson Health Care Group

Koda Health

ThroughCare

Vital Decisions

Affirm Health

MIDEO

New Century Health

Thanacare

Island Health

Honor My Decisions LLC

Advance Directives Segment by Type

Software

Service

Advance Directives Segment by Application

Child

Adult

Advance Directives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Advance Directives status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Advance Directives key companies, revenue, market share, and recent developments.

3. To split the Advance Directives breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Advance Directives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Advance Directives significant trends, drivers, influence factors in global and regions.

6. To analyze Advance Directives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advance Directives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advance Directives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advance Directives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Advance Directives industry.

Chapter 3: Detailed analysis of Advance Directives company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Advance Directives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Advance Directives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Advance Directives Industry Trends Table 2. Advance Directives Industry Drivers Table 3. Advance Directives Industry Opportunities and Challenges Table 4. Advance Directives Industry Restraints Table 5. Global Advance Directives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Advance Directives Revenue Share by Company (2021-2026) Table 7. Global Advance Directives Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Advance Directives Key Company Manufacturing Base & Headquarters Table 9. Global Advance Directives Company, Product Type & Application Table 10. Global Advance Directives Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Advance Directives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Software Table 15. Significant Companies of Service Table 16. Global Advance Directives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Advance Directives Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Advance Directives Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Advance Directives Sales Value Share by Type (2021-2026) Table 20. Global Advance Directives Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Child Table 22. Significant Companies of Adult Table 23. Global Advance Directives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Advance Directives Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Advance Directives Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Advance Directives Sales Value Share by Application (2021-2026) Table 27. Global Advance Directives Sales Value Share by Application (2027-2032) Table 28. Global Advance Directives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Advance Directives Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Advance Directives Sales Value Share by Region (2021-2026) Table 31. Global Advance Directives Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Advance Directives Sales Value Share by Region (2027-2032) Table 33. Global Advance Directives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Advance Directives Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Advance Directives Sales Value Market Share by Country (2021-2026) Table 36. Global Advance Directives Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Advance Directives Sales Value Market Share by Country (2027-2032) Table 38. ADvault Company Information Table 39. ADvault Business Overview Table 40. ADvault Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. ADvault Advance Directives Product Portfolio Table 42. ADvault Recent Development Table 43. VyncaCare Company Information Table 44. VyncaCare Business Overview Table 45. VyncaCare Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. VyncaCare Advance Directives Product Portfolio Table 47. VyncaCare Recent Development Table 48. WiserCareInc Company Information Table 49. WiserCareInc Business Overview Table 50. WiserCareInc Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. WiserCareInc Advance Directives Product Portfolio Table 52. WiserCareInc Recent Development Table 53. Sharp HealthCare Company Information Table 54. Sharp HealthCare Business Overview Table 55. Sharp HealthCare Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sharp HealthCare Advance Directives Product Portfolio Table 57. Sharp HealthCare Recent Development Table 58. ACP Decisions Company Information Table 59. ACP Decisions Business Overview Table 60. ACP Decisions Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. ACP Decisions Advance Directives Product Portfolio Table 62. ACP Decisions Recent Development Table 63. lris Company Information Table 64. lris Business Overview Table 65. lris Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. lris Advance Directives Product Portfolio Table 67. lris Recent Development Table 68. Healthcare Company Information Table 69. Healthcare Business Overview Table 70. Healthcare Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Healthcare Advance Directives Product Portfolio Table 72. Healthcare Recent Development Table 73. Bronson Health Care Group Company Information Table 74. Bronson Health Care Group Business Overview Table 75. Bronson Health Care Group Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bronson Health Care Group Advance Directives Product Portfolio Table 77. Bronson Health Care Group Recent Development Table 78. Koda Health Company Information Table 79. Koda Health Business Overview Table 80. Koda Health Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Koda Health Advance Directives Product Portfolio Table 82. Koda Health Recent Development Table 83. ThroughCare Company Information Table 84. ThroughCare Business Overview Table 85. ThroughCare Advance Directives Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. ThroughCare Advance Directives Product Portfolio Table 87. ThroughCare Recent Development Table 88. Vital Decisions Company Information Table 89. Vital Decisions Business Overview Table 90. Vital Decisions Advance Directives Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Vital Decisions Advance Directives Product Portfolio Table 92. Vital Decisions Recent Development Table 93. Affirm Health Company Information Table 94. Affirm Health Business Overview Table 95. Affirm Health Advance Directives Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Affirm Health Advance Directives Product Portfolio Table 97. Affirm Health Recent Development Table 98. MIDEO Company Information Table 99. MIDEO Business Overview Table 100. MIDEO Advance Directives Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. MIDEO Advance Directives Product Portfolio Table 102. MIDEO Recent Development Table 103. New Century Health Company Information Table 104. New Century Health Business Overview Table 105. New Century Health Advance Directives Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. New Century Health Advance Directives Product Portfolio Table 107. New Century Health Recent Development Table 108. Thanacare Company Information Table 109. Thanacare Business Overview Table 110. Thanacare Advance Directives Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Thanacare Advance Directives Product Portfolio Table 112. Thanacare Recent Development Table 113. Island Health Company Information Table 114. Island Health Business Overview Table 115. Island Health Advance Directives Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Island Health Advance Directives Product Portfolio Table 117. Island Health Recent Development Table 118. Honor My Decisions LLC Company Information Table 119. Honor My Decisions LLC Business Overview Table 120. Honor My Decisions LLC Advance Directives Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Honor My Decisions LLC Advance Directives Product Portfolio Table 122. Honor My Decisions LLC Recent Development Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Advance Directives Product Image Figure 2. Global Advance Directives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advance Directives Market Size (2021-2032) & (US$ Million) Figure 4. Global Advance Directives Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Software Image Figure 8. Service Image Figure 9. Global Advance Directives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Advance Directives Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Advance Directives Sales Value Share by Type (2021-2032) Figure 12. Child Image Figure 13. Adult Image Figure 14. Global Advance Directives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Advance Directives Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Advance Directives Sales Value Share by Application (2021-2032) Figure 17. Global Advance Directives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Advance Directives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Advance Directives Sales Value (2021-2032) & (US$ Million) Figure 20. North America Advance Directives Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Advance Directives Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Advance Directives Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Advance Directives Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Advance Directives Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Advance Directives Sales Value (2021-2032) & (US$ Million) Figure 26. South America Advance Directives Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Advance Directives Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Advance Directives Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Advance Directives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Advance Directives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Advance Directives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Service
Applications
  • Child
  • Adult
Companies covered
  • ADvault
  • VyncaCare
  • WiserCareInc
  • Sharp HealthCare
  • ACP Decisions
  • lris
  • Healthcare
  • Bronson Health Care Group
  • Koda Health
  • ThroughCare
  • Vital Decisions
  • Affirm Health
  • MIDEO
  • New Century Health
  • Thanacare
  • Island Health
  • Honor My Decisions LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Advance Directives Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Advance Directives Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Advance Directives Market Dynamics
  1. 2.1 Advance Directives Industry Trends
  2. 2.2 Advance Directives Industry Drivers
  3. 2.3 Advance Directives Industry Opportunities and Challenges
  4. 2.4 Advance Directives Industry Restraints
3 Advance Directives Market by Company
  1. 3.1 Global Advance Directives Company Revenue Ranking in 2025
  2. 3.2 Global Advance Directives Revenue by Company (2021-2026)
  3. 3.3 Global Advance Directives Company Ranking (2024-2026)
  4. 3.4 Global Advance Directives Company Manufacturing Base and Headquarters
  5. 3.5 Global Advance Directives Company Product Type and Application
  6. 3.6 Global Advance Directives Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Advance Directives Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Advance Directives Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Advance Directives Market by Type
  1. 4.1 Advance Directives Type Introduction
  2. 4.1.1 Software
  3. 4.1.2 Service
  4. 4.2 Global Advance Directives Sales Value by Type
  5. 4.2.1 Global Advance Directives Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Advance Directives Sales Value by Type (2021-2032)
  7. 4.2.3 Global Advance Directives Sales Value Share by Type (2021-2032)
5 Advance Directives Market by Application
  1. 5.1 Advance Directives Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Adult
  4. 5.2 Global Advance Directives Sales Value by Application
  5. 5.2.1 Global Advance Directives Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Advance Directives Sales Value by Application (2021-2032)
  7. 5.2.3 Global Advance Directives Sales Value Share by Application (2021-2032)
6 Advance Directives Regional Value Analysis
  1. 6.1 Global Advance Directives Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Advance Directives Sales Value by Region (2021-2032)
  3. 6.2.1 Global Advance Directives Sales Value by Region: 2021-2026
  4. 6.2.2 Global Advance Directives Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Advance Directives Sales Value (2021-2032)
  7. 6.3.2 North America Advance Directives Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Advance Directives Sales Value (2021-2032)
  10. 6.4.2 Europe Advance Directives Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Advance Directives Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Advance Directives Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Advance Directives Sales Value (2021-2032)
  16. 6.6.2 South America Advance Directives Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Advance Directives Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Advance Directives Sales Value Share by Country, 2025 VS 2032
7 Advance Directives Country-level Value Analysis
  1. 7.1 Global Advance Directives Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Advance Directives Sales Value by Country (2021-2032)
  3. 7.2.1 Global Advance Directives Sales Value by Country (2021-2026)
  4. 7.2.2 Global Advance Directives Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Advance Directives Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Advance Directives Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Advance Directives Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Advance Directives Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Advance Directives Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Advance Directives Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Advance Directives Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Advance Directives Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Advance Directives Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Advance Directives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Advance Directives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Advance Directives Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Advance Directives Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Advance Directives Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Advance Directives Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Advance Directives Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Advance Directives Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Advance Directives Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Advance Directives Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Advance Directives Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Advance Directives Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Advance Directives Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Advance Directives Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Advance Directives Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Advance Directives Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Advance Directives Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Advance Directives Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Advance Directives Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Advance Directives Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Advance Directives Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Advance Directives Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Advance Directives Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Advance Directives Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Advance Directives Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Advance Directives Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Advance Directives Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Advance Directives Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Advance Directives Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Advance Directives Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Advance Directives Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Advance Directives Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Advance Directives Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Advance Directives Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Advance Directives Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Advance Directives Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Advance Directives Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Advance Directives Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Advance Directives Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Advance Directives Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Advance Directives Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Advance Directives Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Advance Directives Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Advance Directives Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Advance Directives Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Advance Directives Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Advance Directives Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Advance Directives Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Advance Directives Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Advance Directives Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Advance Directives Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Advance Directives Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Advance Directives Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Advance Directives Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Advance Directives Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Advance Directives Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Advance Directives Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Advance Directives Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Advance Directives Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Advance Directives Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Advance Directives Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Advance Directives Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Advance Directives Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Advance Directives Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Advance Directives Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Advance Directives Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Advance Directives Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Advance Directives Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Advance Directives Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Advance Directives Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Advance Directives Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Advance Directives Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Advance Directives Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Advance Directives Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Advance Directives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ADvault
  2. 8.1.1 ADvault Company Information
  3. 8.1.2 ADvault Business Overview
  4. 8.1.3 ADvault Advance Directives Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ADvault Advance Directives Product Portfolio
  6. 8.1.5 ADvault Recent Developments
  7. 8.2 VyncaCare
  8. 8.2.1 VyncaCare Company Information
  9. 8.2.2 VyncaCare Business Overview
  10. 8.2.3 VyncaCare Advance Directives Revenue and Gross Margin (2021-2026)
  11. 8.2.4 VyncaCare Advance Directives Product Portfolio
  12. 8.2.5 VyncaCare Recent Developments
  13. 8.3 WiserCareInc
  14. 8.3.1 WiserCareInc Company Information
  15. 8.3.2 WiserCareInc Business Overview
  16. 8.3.3 WiserCareInc Advance Directives Revenue and Gross Margin (2021-2026)
  17. 8.3.4 WiserCareInc Advance Directives Product Portfolio
  18. 8.3.5 WiserCareInc Recent Developments
  19. 8.4 Sharp HealthCare
  20. 8.4.1 Sharp HealthCare Company Information
  21. 8.4.2 Sharp HealthCare Business Overview
  22. 8.4.3 Sharp HealthCare Advance Directives Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sharp HealthCare Advance Directives Product Portfolio
  24. 8.4.5 Sharp HealthCare Recent Developments
  25. 8.5 ACP Decisions
  26. 8.5.1 ACP Decisions Company Information
  27. 8.5.2 ACP Decisions Business Overview
  28. 8.5.3 ACP Decisions Advance Directives Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ACP Decisions Advance Directives Product Portfolio
  30. 8.5.5 ACP Decisions Recent Developments
  31. 8.6 lris
  32. 8.6.1 lris Company Information
  33. 8.6.2 lris Business Overview
  34. 8.6.3 lris Advance Directives Revenue and Gross Margin (2021-2026)
  35. 8.6.4 lris Advance Directives Product Portfolio
  36. 8.6.5 lris Recent Developments
  37. 8.7 Healthcare
  38. 8.7.1 Healthcare Company Information
  39. 8.7.2 Healthcare Business Overview
  40. 8.7.3 Healthcare Advance Directives Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Healthcare Advance Directives Product Portfolio
  42. 8.7.5 Healthcare Recent Developments
  43. 8.8 Bronson Health Care Group
  44. 8.8.1 Bronson Health Care Group Company Information
  45. 8.8.2 Bronson Health Care Group Business Overview
  46. 8.8.3 Bronson Health Care Group Advance Directives Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bronson Health Care Group Advance Directives Product Portfolio
  48. 8.8.5 Bronson Health Care Group Recent Developments
  49. 8.9 Koda Health
  50. 8.9.1 Koda Health Company Information
  51. 8.9.2 Koda Health Business Overview
  52. 8.9.3 Koda Health Advance Directives Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Koda Health Advance Directives Product Portfolio
  54. 8.9.5 Koda Health Recent Developments
  55. 8.10 ThroughCare
  56. 8.10.1 ThroughCare Company Information
  57. 8.10.2 ThroughCare Business Overview
  58. 8.10.3 ThroughCare Advance Directives Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ThroughCare Advance Directives Product Portfolio
  60. 8.10.5 ThroughCare Recent Developments
  61. 8.11 Vital Decisions
  62. 8.11.1 Vital Decisions Company Information
  63. 8.11.2 Vital Decisions Business Overview
  64. 8.11.3 Vital Decisions Advance Directives Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vital Decisions Advance Directives Product Portfolio
  66. 8.11.5 Vital Decisions Recent Developments
  67. 8.12 Affirm Health
  68. 8.12.1 Affirm Health Company Information
  69. 8.12.2 Affirm Health Business Overview
  70. 8.12.3 Affirm Health Advance Directives Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Affirm Health Advance Directives Product Portfolio
  72. 8.12.5 Affirm Health Recent Developments
  73. 8.13 MIDEO
  74. 8.13.1 MIDEO Company Information
  75. 8.13.2 MIDEO Business Overview
  76. 8.13.3 MIDEO Advance Directives Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MIDEO Advance Directives Product Portfolio
  78. 8.13.5 MIDEO Recent Developments
  79. 8.14 New Century Health
  80. 8.14.1 New Century Health Company Information
  81. 8.14.2 New Century Health Business Overview
  82. 8.14.3 New Century Health Advance Directives Revenue and Gross Margin (2021-2026)
  83. 8.14.4 New Century Health Advance Directives Product Portfolio
  84. 8.14.5 New Century Health Recent Developments
  85. 8.15 Thanacare
  86. 8.15.1 Thanacare Company Information
  87. 8.15.2 Thanacare Business Overview
  88. 8.15.3 Thanacare Advance Directives Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Thanacare Advance Directives Product Portfolio
  90. 8.15.5 Thanacare Recent Developments
  91. 8.16 Island Health
  92. 8.16.1 Island Health Company Information
  93. 8.16.2 Island Health Business Overview
  94. 8.16.3 Island Health Advance Directives Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Island Health Advance Directives Product Portfolio
  96. 8.16.5 Island Health Recent Developments
  97. 8.17 Honor My Decisions LLC
  98. 8.17.1 Honor My Decisions LLC Company Information
  99. 8.17.2 Honor My Decisions LLC Business Overview
  100. 8.17.3 Honor My Decisions LLC Advance Directives Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Honor My Decisions LLC Advance Directives Product Portfolio
  102. 8.17.5 Honor My Decisions LLC Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst